{"transactions":[{"id":926841,"issuer":{"id":6620,"kind":"organization","name":"Rafael Holdings, Inc.","symbol":"RFL"},"owners":[{"id":68386,"kind":"person","name":"Sieger Markus","position":1,"cik":"0001337143","reported_name":"Sieger Markus","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class B Common Stock, par value $.01 per share","published_at":"2026-01-30T16:01:16.000Z","date":"2026-01-28","kind":"grant","planned":false,"acquired":true,"shares":29528,"price":1.27,"value":37500.56,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of Restricted Stock that vests in full immediately."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the average closing price of the Issuer's Class B common stock during December 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Consists of 29,528 fully vested shares of Restricted Stock and 190,182 shares held directly."}],"balance_after":219710,"source":{"system":"sec-edgar","filing":"0001193125-26-031749","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1337143/000119312526031749/ownership.xml","form_type":"4"}},{"id":1130355,"issuer":{"id":6620,"kind":"organization","name":"Rafael Holdings, Inc.","symbol":"RFL"},"owners":[{"id":68386,"kind":"person","name":"Sieger Markus","position":1,"cik":"0001337143","reported_name":"Sieger Markus","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Subscription Rights (right to buy)","published_at":"2025-05-29T15:04:58.000Z","date":"2025-05-27","kind":"other","planned":false,"acquired":false,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":1.28,"exercise_date":"2025-05-13","expiration_date":"2025-05-29","underlying":"Class B Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0000950170-25-078854","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1337143/000095017025078854/ownership.xml","form_type":"4"}},{"id":1130354,"issuer":{"id":6620,"kind":"organization","name":"Rafael Holdings, Inc.","symbol":"RFL"},"owners":[{"id":68386,"kind":"person","name":"Sieger Markus","position":1,"cik":"0001337143","reported_name":"Sieger Markus","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class B Common Stock, par value $.01 per share","published_at":"2025-05-29T15:04:58.000Z","date":"2025-05-27","kind":"other","planned":false,"acquired":true,"shares":35000,"price":1.28,"value":44800.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the exercise of subscription rights in the Issuer's Rights Offering."}],"balance_after":190182,"source":{"system":"sec-edgar","filing":"0000950170-25-078854","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1337143/000095017025078854/ownership.xml","form_type":"4"}},{"id":1237025,"issuer":{"id":82635,"kind":"organization","name":"Cyclo Therapeutics, Inc.","symbol":"CYTH"},"owners":[{"id":68386,"kind":"person","name":"Sieger Markus","position":1,"cik":"0001337143","reported_name":"Sieger Markus","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-03-03T11:42:36.000Z","date":"2025-02-27","kind":"grant","planned":false,"acquired":true,"shares":58138,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the grant of fully-vested shares of common stock that the Reporting Person elected to receive in lieu of cash compensation under the issuer's non-employee director compensation policy. Grant reflects director compensation for the fourth quarter of 2024 and from January 1, 2025 through March 25, 2025. The number of shares received in lieu of cash was calculated based on the closing price of $0.77 per share of common stock on February 26, 2025."}],"balance_after":440260,"source":{"system":"sec-edgar","filing":"0001437749-25-005846","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/922247/000143774925005846/rdgdoc.xml","form_type":"4"}},{"id":1362565,"issuer":{"id":82635,"kind":"organization","name":"Cyclo Therapeutics, Inc.","symbol":"CYTH"},"owners":[{"id":68386,"kind":"person","name":"Sieger Markus","position":1,"cik":"0001337143","reported_name":"Sieger Markus","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-11-18T14:10:12.000Z","date":"2024-11-15","kind":"grant","planned":false,"acquired":true,"shares":35022,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the grant of fully-vested shares of common stock that the Reporting Person elected to receive in lieu of cash compensation under the issuer's non-employee director compensation policy. Grant reflects director compensation for the third quarter of 2024. The number of shares received in lieu of cash was calculated based on the closing price of $0.66 per share of common stock on November 14, 2024."}],"balance_after":382122,"source":{"system":"sec-edgar","filing":"0001437749-24-035586","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/922247/000143774924035586/rdgdoc.xml","form_type":"4"}},{"id":1428249,"issuer":{"id":82635,"kind":"organization","name":"Cyclo Therapeutics, Inc.","symbol":"CYTH"},"owners":[{"id":68386,"kind":"person","name":"Sieger Markus","position":1,"cik":"0001337143","reported_name":"Sieger Markus","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-08-20T13:47:47.000Z","date":"2024-08-16","kind":"grant","planned":false,"acquired":true,"shares":18354,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the grant of fully-vested shares of common stock that the Reporting Person elected to receive in lieu of cash compensation under the issuer's non-employee director compensation policy. Grant reflects director compensation for the second quarter of 2024. The number of shares received in lieu of cash was calculated based on the closing price of $1.26 per share of common stock on August 16, 2024."}],"balance_after":347100,"source":{"system":"sec-edgar","filing":"0001437749-24-027326","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/922247/000143774924027326/rdgdoc.xml","form_type":"4"}},{"id":1490823,"issuer":{"id":82635,"kind":"organization","name":"Cyclo Therapeutics, Inc.","symbol":"CYTH"},"owners":[{"id":68386,"kind":"person","name":"Sieger Markus","position":1,"cik":"0001337143","reported_name":"Sieger Markus","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-05T17:10:56.000Z","date":"2024-06-03","kind":"grant","planned":false,"acquired":true,"shares":15562,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests over a one year period in equal quarterly installments."}],"balance_after":15562,"derivative":{"exercise_price":1.28,"expiration_date":"2034-06-03","underlying":"Common Stock","underlying_shares":15562},"source":{"system":"sec-edgar","filing":"0001437749-24-019348","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/922247/000143774924019348/rdgdoc.xml","form_type":"4"}},{"id":1490822,"issuer":{"id":82635,"kind":"organization","name":"Cyclo Therapeutics, Inc.","symbol":"CYTH"},"owners":[{"id":68386,"kind":"person","name":"Sieger Markus","position":1,"cik":"0001337143","reported_name":"Sieger Markus","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-06-05T17:10:56.000Z","date":"2024-06-03","kind":"grant","planned":false,"acquired":true,"shares":18067,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the grant of fully-vested shares of common stock that the Reporting Person elected to receive in lieu of cash compensation under the issuer's non-employee director compensation policy. Grant reflects director compensation for the first quarter of 2024. The number of shares received in lieu of cash was calculated based on the closing price of $1.28 per share of common stock on June 3, 2024."}],"balance_after":328746,"source":{"system":"sec-edgar","filing":"0001437749-24-019348","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/922247/000143774924019348/rdgdoc.xml","form_type":"4"}},{"id":1641653,"issuer":{"id":82635,"kind":"organization","name":"Cyclo Therapeutics, Inc.","symbol":"CYTH"},"owners":[{"id":68386,"kind":"person","name":"Sieger Markus","position":1,"cik":"0001337143","reported_name":"Sieger Markus","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-02-15T16:46:21.000Z","date":"2024-02-13","kind":"grant","planned":false,"acquired":true,"shares":14004,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the grant of fully-vested shares of common stock that the Reporting Person elected to receive in lieu of cash compensation under the Issuer's non-employee director compensation policy. Grant reflects director compensation for the fourth quarter of 2023. The number of shares received in lieu of cash was calculated based on the closing price of $1.58 per share of common stock on February 13, 2024."}],"balance_after":310679,"source":{"system":"sec-edgar","filing":"0001437749-24-004388","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/922247/000143774924004388/rdgdoc.xml","form_type":"4"}},{"id":1727187,"issuer":{"id":82635,"kind":"organization","name":"Cyclo Therapeutics, Inc.","symbol":"CYTH"},"owners":[{"id":68386,"kind":"person","name":"Sieger Markus","position":1,"cik":"0001337143","reported_name":"Sieger Markus","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-11-30T09:05:02.000Z","date":"2023-11-28","kind":"grant","planned":false,"acquired":true,"shares":16512,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the grant of fully-vested shares of common stock that the Reporting Person elected to receive in lieu of cash compensation under the Issuer's non-employee director compensation policy. Grant reflects director compensation for the third quarter of 2023. The number of shares received in lieu of cash was calculated based on the closing price of $1.34 per share of common stock on November 28, 2023."}],"balance_after":296675,"source":{"system":"sec-edgar","filing":"0001437749-23-033216","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/922247/000143774923033216/rdgdoc.xml","form_type":"4"}},{"id":1756413,"issuer":{"id":82635,"kind":"organization","name":"Cyclo Therapeutics, Inc.","symbol":"CYTH"},"owners":[{"id":68386,"kind":"person","name":"Sieger Markus","position":1,"cik":"0001337143","reported_name":"Sieger Markus","relationship":{"director":true}}],"security":"Warrant to Purchase Common Stock","published_at":"2023-10-23T06:06:43.000Z","date":"2023-10-20","kind":"purchase","planned":false,"acquired":true,"shares":65869,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person exercised vested Warrants (the \"Original Warrants\") to purchase 59,881 shares of the Issuer's common stock pursuant to a Securities Purchase Agreement dated October 20, 2023 (\"Closing Date\").  The Reporting Person exercised his Original Warrant in full on or prior to the Closing Date in consideration of the receipt of new warrants with an exercise price equal to $0.95 per share, to purchase 110% of the shares of the Issuer's common stock covered under the Original Warrants."}],"balance_after":65869,"derivative":{"exercise_price":0.95,"exercise_date":"2023-10-20","expiration_date":"2027-10-20","underlying":"Common Stock","underlying_shares":65869},"source":{"system":"sec-edgar","filing":"0001437749-23-028702","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/922247/000143774923028702/rdgdoc.xml","form_type":"4"}},{"id":1756412,"issuer":{"id":82635,"kind":"organization","name":"Cyclo Therapeutics, Inc.","symbol":"CYTH"},"owners":[{"id":68386,"kind":"person","name":"Sieger Markus","position":1,"cik":"0001337143","reported_name":"Sieger Markus","relationship":{"director":true}}],"security":"Warrant to Purchase Common Stock","published_at":"2023-10-23T06:06:43.000Z","date":"2023-10-20","kind":"other","planned":false,"acquired":false,"shares":59881,"price":0.125,"value":7485.125,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":0.71,"exercise_date":"2023-04-20","expiration_date":"2030-04-20","underlying":"Common Stock","underlying_shares":59881},"source":{"system":"sec-edgar","filing":"0001437749-23-028702","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/922247/000143774923028702/rdgdoc.xml","form_type":"4"}},{"id":1756411,"issuer":{"id":82635,"kind":"organization","name":"Cyclo Therapeutics, Inc.","symbol":"CYTH"},"owners":[{"id":68386,"kind":"person","name":"Sieger Markus","position":1,"cik":"0001337143","reported_name":"Sieger Markus","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-10-23T06:06:43.000Z","date":"2023-10-20","kind":"other","planned":false,"acquired":true,"shares":59881,"price":0.71,"value":42515.51,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person exercised vested Warrants (the \"Original Warrants\") to purchase 59,881 shares of the Issuer's common stock pursuant to a Securities Purchase Agreement dated October 20, 2023 (\"Closing Date\").  The Reporting Person exercised his Original Warrant in full on or prior to the Closing Date in consideration of the receipt of new warrants with an exercise price equal to $0.95 per share, to purchase 110% of the shares of the Issuer's common stock covered under the Original Warrants."}],"balance_after":280163,"source":{"system":"sec-edgar","filing":"0001437749-23-028702","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/922247/000143774923028702/rdgdoc.xml","form_type":"4"}},{"id":1800039,"issuer":{"id":82635,"kind":"organization","name":"Cyclo Therapeutics, Inc.","symbol":"CYTH"},"owners":[{"id":68386,"kind":"person","name":"Sieger Markus","position":1,"cik":"0001337143","reported_name":"Sieger Markus","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-08-22T16:06:29.000Z","date":"2023-08-18","kind":"grant","planned":false,"acquired":true,"shares":16269,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the grant of fully-vested shares of common stock that the Reporting Person elected to receive in lieu of cash compensation under the Issuer's non-employee director compensation policy. Grant reflects director compensation for the second quarter of 2023. The number of shares received in lieu of cash was calculated based on the closing price of $1.36 per share of common stock on August 18, 2023."}],"balance_after":220282,"source":{"system":"sec-edgar","filing":"0001437749-23-024415","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/922247/000143774923024415/rdgdoc.xml","form_type":"4"}},{"id":1887523,"issuer":{"id":82635,"kind":"organization","name":"Cyclo Therapeutics, Inc.","symbol":"CYTH"},"owners":[{"id":68386,"kind":"person","name":"Sieger Markus","position":1,"cik":"0001337143","reported_name":"Sieger Markus","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-05-18T16:39:01.000Z","date":"2023-05-17","kind":"grant","planned":false,"acquired":true,"shares":42962,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the grant of fully-vested shares of common stock that the Reporting Person elected to receive in lieu of cash compensation under the Issuer's non-employee director compensation policy. Grant reflects director compensation for the fourth quarter of 2022 and first quarter of 2023. The number of shares received in lieu of cash was calculated based on the closing price of 1.03 per share of common stock on May 16, 2023."}],"balance_after":204013,"source":{"system":"sec-edgar","filing":"0001437749-23-015129","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/922247/000143774923015129/rdgdoc.xml","form_type":"4"}},{"id":1915112,"issuer":{"id":82635,"kind":"organization","name":"Cyclo Therapeutics, Inc.","symbol":"CYTH"},"owners":[{"id":68386,"kind":"person","name":"Sieger Markus","position":1,"cik":"0001337143","reported_name":"Sieger Markus","relationship":{"director":true}}],"security":"Warrant to Purchase Common Stock","published_at":"2023-04-24T10:27:56.000Z","date":"2023-04-20","kind":"purchase","planned":false,"acquired":true,"shares":59881,"price":0.125,"value":7485.125,"ownership":{"direct":true},"balance_after":59881,"derivative":{"exercise_price":0.71,"exercise_date":"2023-04-20","expiration_date":"2030-04-20","underlying":"Common Stock","underlying_shares":59881},"source":{"system":"sec-edgar","filing":"0001437749-23-010876","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/922247/000143774923010876/rdgdoc.xml","form_type":"4"}},{"id":1915111,"issuer":{"id":82635,"kind":"organization","name":"Cyclo Therapeutics, Inc.","symbol":"CYTH"},"owners":[{"id":68386,"kind":"person","name":"Sieger Markus","position":1,"cik":"0001337143","reported_name":"Sieger Markus","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-04-24T10:27:56.000Z","date":"2023-04-20","kind":"purchase","planned":false,"acquired":true,"shares":59881,"price":0.71,"value":42515.51,"ownership":{"direct":true},"balance_after":161051,"source":{"system":"sec-edgar","filing":"0001437749-23-010876","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/922247/000143774923010876/rdgdoc.xml","form_type":"4"}},{"id":1961696,"issuer":{"id":82635,"kind":"organization","name":"Cyclo Therapeutics, Inc.","symbol":"CYTH"},"owners":[{"id":68386,"kind":"person","name":"Sieger Markus","position":1,"cik":"0001337143","reported_name":"Sieger Markus","relationship":{"director":true}}],"security":"Stock Option (Right to buy)","published_at":"2023-03-09T17:08:03.000Z","date":"2023-03-07","kind":"grant","acquired":true,"shares":3350,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests over a one year period in equal quarterly installments."}],"balance_after":3350,"derivative":{"exercise_price":1.28,"expiration_date":"2033-03-07","underlying":"Common Stock","underlying_shares":3350},"source":{"system":"sec-edgar","filing":"0001437749-23-006000","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/922247/000143774923006000/rdgdoc.xml","form_type":"4"}},{"id":2121556,"issuer":{"id":82635,"kind":"organization","name":"Cyclo Therapeutics, Inc.","symbol":"CYTH"},"owners":[{"id":68386,"kind":"person","name":"Sieger Markus","position":1,"cik":"0001337143","reported_name":"Sieger Markus","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-11-09T16:02:52.000Z","date":"2022-11-08","kind":"grant","acquired":true,"shares":9496,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the grant of fully-vested shares of common stock that the Reporting Person elected to receive in lieu of cash compensation under the Issuer's non-employee director compensation policy. Grant reflects director compensation for the third quarter of 2022. The number of shares received in lieu of cash was calculated based on the closing price of 1.17 per share of common stock on November 7, 2022."}],"balance_after":101170,"source":{"system":"sec-edgar","filing":"0001437749-22-026585","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/922247/000143774922026585/rdgdoc.xml","form_type":"4"}},{"id":2194818,"issuer":{"id":82635,"kind":"organization","name":"Cyclo Therapeutics, Inc.","symbol":"CYTH"},"owners":[{"id":68386,"kind":"person","name":"Sieger Markus","position":1,"cik":"0001337143","reported_name":"Sieger Markus","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-08-04T16:03:26.000Z","date":"2022-08-02","kind":"grant","acquired":true,"shares":5762,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the grant of fully-vested shares of common stock that the Reporting Person elected to receive in lieu of cash compensation under the Issuer's non-employee director compensation policy. Grant reflects director compensation for the second quarter of 2022. The number of shares received in lieu of cash was calculated based on the closing price of 1.92 per share of common stock on August 1, 2022."}],"balance_after":91674,"source":{"system":"sec-edgar","filing":"0001437749-22-018880","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/922247/000143774922018880/rdgdoc.xml","form_type":"4"}},{"id":2282879,"issuer":{"id":82635,"kind":"organization","name":"Cyclo Therapeutics, Inc.","symbol":"CYTH"},"owners":[{"id":68386,"kind":"person","name":"Sieger Markus","position":1,"cik":"0001337143","reported_name":"Sieger Markus","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-05-04T21:27:48.000Z","date":"2022-05-03","kind":"grant","acquired":true,"shares":4223,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the grant of fully-vested shares of common stock that the Reporting Person elected to receive in lieu of cash compensation under the Issuer's non-employee director compensation policy. Grant reflects director compensation for the first quarter of 2022. The number of shares received in lieu of cash was calculated based on the closing price of 2.62 per share of common stock on May 2, 2022."}],"balance_after":85912,"source":{"system":"sec-edgar","filing":"0001437749-22-010957","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/922247/000143774922010957/rdgdoc.xml","form_type":"4"}},{"id":2314463,"issuer":{"id":82635,"kind":"organization","name":"Cyclo Therapeutics, Inc.","symbol":"CYTH"},"owners":[{"id":68386,"kind":"person","name":"Sieger Markus","position":1,"cik":"0001337143","reported_name":"Sieger Markus","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-03-30T10:28:07.000Z","date":"2022-03-29","kind":"purchase","acquired":true,"shares":10000,"price":2.73,"value":27300.0,"ownership":{"direct":true},"balance_after":81689,"source":{"system":"sec-edgar","filing":"0001437749-22-007616","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/922247/000143774922007616/rdgdoc.xml","form_type":"4"}},{"id":2419930,"issuer":{"id":82635,"kind":"organization","name":"Cyclo Therapeutics, Inc.","symbol":"CYTH"},"owners":[{"id":68386,"kind":"person","name":"Sieger Markus","position":1,"cik":"0001337143","reported_name":"Sieger Markus","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-02-01T09:23:43.000Z","date":"2022-01-28","kind":"grant","acquired":true,"shares":4075,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the grant of fully-vested shares of common stock that the Reporting Person elected to receive in lieu of cash compensation under the Issuer's non-employee director compensation policy. Grant reflects director compensation for the fourth quarter of 2021. The number of shares received in lieu of cash was calculated based on the closing price of 3.62 per share of common stock on January 28, 2022."}],"balance_after":71689,"source":{"system":"sec-edgar","filing":"0001437749-22-002054","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/922247/000143774922002054/rdgdoc.xml","form_type":"4"}},{"id":2587189,"issuer":{"id":82635,"kind":"organization","name":"Cyclo Therapeutics, Inc.","symbol":"CYTH"},"owners":[{"id":68386,"kind":"person","name":"Sieger Markus","position":1,"cik":"0001337143","reported_name":"Sieger Markus","relationship":{"director":true}}],"security":"Stock Option (Right to buy)","published_at":"2021-08-30T19:03:26.000Z","date":"2021-08-27","kind":"grant","acquired":true,"shares":6700,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":6700,"derivative":{"exercise_price":7.46,"exercise_date":"2021-08-27","expiration_date":"2031-08-27","underlying":"Common Stock","underlying_shares":6700},"source":{"system":"sec-edgar","filing":"0001437749-21-021209","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/922247/000143774921021209/rdgdoc.xml","form_type":"4"}},{"id":2662062,"issuer":{"id":82635,"kind":"organization","name":"Cyclo Therapeutics, Inc.","symbol":"CYTH"},"owners":[{"id":68386,"kind":"person","name":"Sieger Markus","position":1,"cik":"0001337143","reported_name":"Sieger Markus","relationship":{"director":true}}],"security":"Warrant to Purchase Common Stock","published_at":"2021-06-21T09:14:47.000Z","date":"2021-06-18","kind":"purchase","acquired":true,"shares":2500,"price":6,"value":15000.0,"ownership":{"direct":true},"balance_after":40000,"derivative":{"exercise_price":5,"exercise_date":"2020-12-11","expiration_date":"2025-12-11","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001437749-21-015195","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/922247/000143774921015195/rdgdoc.xml","form_type":"4"}},{"id":2662061,"issuer":{"id":82635,"kind":"organization","name":"Cyclo Therapeutics, Inc.","symbol":"CYTH"},"owners":[{"id":68386,"kind":"person","name":"Sieger Markus","position":1,"cik":"0001337143","reported_name":"Sieger Markus","relationship":{"director":true}}],"security":"Warrant to Purchase Common Stock","published_at":"2021-06-21T09:14:47.000Z","date":"2021-06-18","kind":"purchase","acquired":true,"shares":7500,"price":6.5,"value":48750.0,"ownership":{"direct":true},"balance_after":37500,"derivative":{"exercise_price":5,"exercise_date":"2020-12-11","expiration_date":"2025-12-11","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001437749-21-015195","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/922247/000143774921015195/rdgdoc.xml","form_type":"4"}},{"id":2699618,"issuer":{"id":82635,"kind":"organization","name":"Cyclo Therapeutics, Inc.","symbol":"CYTH"},"owners":[{"id":68386,"kind":"person","name":"Sieger Markus","position":1,"cik":"0001337143","reported_name":"Sieger Markus","relationship":{"director":true}}],"security":"Warrant to Purchase Common Stock","published_at":"2021-05-24T11:08:19.000Z","date":"2021-05-21","kind":"purchase","acquired":true,"shares":3482,"price":3.65,"value":12709.3,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price.  These Warrants were purchased in multiple transactions at prices ranging from $3.55 to $3.90, inclusive. The reporting person undertakes to provide to the Issuer and the staff of the Securities and Exchange Commission, on request, full information regarding the number of warrants purchased at each separate price within the foregoing ranges."}],"balance_after":30000,"derivative":{"exercise_price":5,"exercise_date":"2020-12-11","expiration_date":"2025-12-11","underlying":"Common Stock","underlying_shares":3482},"source":{"system":"sec-edgar","filing":"0001437749-21-013106","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/922247/000143774921013106/rdgdoc.xml","form_type":"4"}},{"id":2701742,"issuer":{"id":82635,"kind":"organization","name":"Cyclo Therapeutics, Inc.","symbol":"CYTH"},"owners":[{"id":68386,"kind":"person","name":"Sieger Markus","position":1,"cik":"0001337143","reported_name":"Sieger Markus","relationship":{"director":true}}],"security":"Warrant to Purchase Common Stock","published_at":"2021-05-21T11:54:16.000Z","date":"2021-05-20","kind":"purchase","acquired":true,"shares":2312,"price":3.19,"value":7375.28,"ownership":{"direct":true},"balance_after":26518,"derivative":{"exercise_price":5,"exercise_date":"2020-12-11","expiration_date":"2025-12-11","underlying":"Common Stock","underlying_shares":2312},"source":{"system":"sec-edgar","filing":"0001437749-21-013021","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/922247/000143774921013021/rdgdoc.xml","form_type":"4"}},{"id":2701741,"issuer":{"id":82635,"kind":"organization","name":"Cyclo Therapeutics, Inc.","symbol":"CYTH"},"owners":[{"id":68386,"kind":"person","name":"Sieger Markus","position":1,"cik":"0001337143","reported_name":"Sieger Markus","relationship":{"director":true}}],"security":"Warrant to Purchase Common Stock","published_at":"2021-05-21T11:54:16.000Z","date":"2021-05-19","kind":"purchase","acquired":true,"shares":9206,"price":3.01,"value":27710.06,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price.  These Warrants were purchased in multiple transactions at prices ranging from $2.79 to $3.20, inclusive. The reporting person undertakes to provide to the Issuer and the staff of the Securities and Exchange Commission, on request, full information regarding the number of warrants purchased at each separate price within the foregoing ranges."}],"balance_after":24206,"derivative":{"exercise_price":5,"exercise_date":"2020-12-11","expiration_date":"2025-12-11","underlying":"Common Stock","underlying_shares":9206},"source":{"system":"sec-edgar","filing":"0001437749-21-013021","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/922247/000143774921013021/rdgdoc.xml","form_type":"4"}},{"id":2768546,"issuer":{"id":82635,"kind":"organization","name":"Cyclo Therapeutics, Inc.","symbol":"CYTH"},"owners":[{"id":68386,"kind":"person","name":"Sieger Markus","position":1,"cik":"0001337143","reported_name":"Sieger Markus","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-03-30T13:26:08.000Z","date":"2021-03-29","kind":"purchase","acquired":true,"shares":10000,"price":8.1,"value":81000.0,"ownership":{"direct":true},"balance_after":67614,"source":{"system":"sec-edgar","filing":"0001437749-21-007619","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/922247/000143774921007619/rdgdoc.xml","form_type":"4"}},{"id":2893931,"issuer":{"id":82635,"kind":"organization","name":"Cyclo Therapeutics, Inc.","symbol":"CYTH"},"owners":[{"id":68386,"kind":"person","name":"Sieger Markus","position":1,"cik":"0001337143","reported_name":"Sieger Markus","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-01-27T08:36:47.000Z","date":"2021-01-26","kind":"purchase","acquired":true,"shares":2201,"price":6.6,"value":14526.6,"ownership":{"direct":true},"balance_after":57614,"source":{"system":"sec-edgar","filing":"0001437749-21-001338","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/922247/000143774921001338/rdgdoc.xml","form_type":"4"}},{"id":2893930,"issuer":{"id":82635,"kind":"organization","name":"Cyclo Therapeutics, Inc.","symbol":"CYTH"},"owners":[{"id":68386,"kind":"person","name":"Sieger Markus","position":1,"cik":"0001337143","reported_name":"Sieger Markus","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-01-27T08:36:47.000Z","date":"2021-01-25","kind":"purchase","acquired":true,"shares":3400,"price":6.36,"value":21624.0,"ownership":{"direct":true},"balance_after":55413,"source":{"system":"sec-edgar","filing":"0001437749-21-001338","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/922247/000143774921001338/rdgdoc.xml","form_type":"4"}},{"id":2893929,"issuer":{"id":82635,"kind":"organization","name":"Cyclo Therapeutics, Inc.","symbol":"CYTH"},"owners":[{"id":68386,"kind":"person","name":"Sieger Markus","position":1,"cik":"0001337143","reported_name":"Sieger Markus","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-01-27T08:36:47.000Z","date":"2021-01-25","kind":"purchase","acquired":true,"shares":1400,"price":6.35,"value":8890.0,"ownership":{"direct":true},"balance_after":52013,"source":{"system":"sec-edgar","filing":"0001437749-21-001338","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/922247/000143774921001338/rdgdoc.xml","form_type":"4"}},{"id":2893928,"issuer":{"id":82635,"kind":"organization","name":"Cyclo Therapeutics, Inc.","symbol":"CYTH"},"owners":[{"id":68386,"kind":"person","name":"Sieger Markus","position":1,"cik":"0001337143","reported_name":"Sieger Markus","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-01-27T08:36:47.000Z","date":"2021-01-25","kind":"purchase","acquired":true,"shares":2999,"price":6.2,"value":18593.8,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Since the date of the reporting person's last ownership report, the reporting person transferred 25,115 shares of Common Stock to his former spouse pursuant to a domestic relations order, and does not beneficially own any of such shares."}],"balance_after":50613,"source":{"system":"sec-edgar","filing":"0001437749-21-001338","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/922247/000143774921001338/rdgdoc.xml","form_type":"4"}},{"id":2947299,"issuer":{"id":82635,"kind":"organization","name":"Cyclo Therapeutics, Inc.","symbol":"CYTH"},"owners":[{"id":68386,"kind":"person","name":"Sieger Markus","position":1,"cik":"0001337143","reported_name":"Sieger Markus","relationship":{"director":true}}],"security":"Warrant to Purchase Common Stock","published_at":"2020-12-14T16:03:41.000Z","date":"2020-12-11","kind":"purchase","acquired":true,"shares":15000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities consist of 15,000 \"Units\" purchased by the reporting person for $5.00 per Unit.  Each Unit consists of one share of Common Stock and a warrant to purchase one share of Common Stock."}],"balance_after":15000,"derivative":{"exercise_price":5,"exercise_date":"2020-12-11","expiration_date":"2025-12-11","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001437749-20-025286","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/922247/000143774920025286/rdgdoc.xml","form_type":"4"}},{"id":2947298,"issuer":{"id":82635,"kind":"organization","name":"Cyclo Therapeutics, Inc.","symbol":"CYTH"},"owners":[{"id":68386,"kind":"person","name":"Sieger Markus","position":1,"cik":"0001337143","reported_name":"Sieger Markus","relationship":{"director":true}}],"security":"Common Stock","published_at":"2020-12-14T16:03:41.000Z","date":"2020-12-11","kind":"purchase","acquired":true,"shares":15000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities consist of 15,000 \"Units\" purchased by the reporting person for $5.00 per Unit.  Each Unit consists of one share of Common Stock and a warrant to purchase one share of Common Stock."}],"balance_after":72729,"source":{"system":"sec-edgar","filing":"0001437749-20-025286","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/922247/000143774920025286/rdgdoc.xml","form_type":"4"}},{"id":3043997,"issuer":{"id":82635,"kind":"organization","name":"Cyclo Therapeutics, Inc.","symbol":"CYTH"},"owners":[{"id":68386,"kind":"person","name":"Sieger Markus","position":1,"cik":"0001337143","reported_name":"Sieger Markus","relationship":{"director":true}}],"security":"Warrant to Purchase Common Stock","published_at":"2020-08-31T09:26:56.000Z","date":"2020-08-27","kind":"purchase","acquired":true,"shares":750000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities consist of 750,000 \"Units\" purchased by the reporting person for $0.10 per Unit.  Each Unit consists of one share of Common Stock and a warrant to purchase one share of Common Stock."}],"balance_after":750000,"derivative":{"exercise_price":0.15,"exercise_date":"2020-08-27","expiration_date":"2027-08-27","underlying":"Common Stock","underlying_shares":750000},"source":{"system":"sec-edgar","filing":"0001437749-20-018982","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/922247/000143774920018982/rdgdoc.xml","form_type":"4"}},{"id":3043996,"issuer":{"id":82635,"kind":"organization","name":"Cyclo Therapeutics, Inc.","symbol":"CYTH"},"owners":[{"id":68386,"kind":"person","name":"Sieger Markus","position":1,"cik":"0001337143","reported_name":"Sieger Markus","relationship":{"director":true}}],"security":"Common Stock","published_at":"2020-08-31T09:26:56.000Z","date":"2020-08-27","kind":"purchase","acquired":true,"shares":750000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities consist of 750,000 \"Units\" purchased by the reporting person for $0.10 per Unit.  Each Unit consists of one share of Common Stock and a warrant to purchase one share of Common Stock."}],"balance_after":5772857,"source":{"system":"sec-edgar","filing":"0001437749-20-018982","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/922247/000143774920018982/rdgdoc.xml","form_type":"4"}},{"id":3169471,"issuer":{"id":82635,"kind":"organization","name":"Cyclo Therapeutics, Inc.","symbol":"CYTH"},"owners":[{"id":68386,"kind":"person","name":"Sieger Markus","position":1,"cik":"0001337143","reported_name":"Sieger Markus","relationship":{"director":true}}],"security":"Common Stock","published_at":"2020-04-27T16:05:37.000Z","date":"2020-04-24","kind":"purchase","acquired":true,"shares":500000,"price":0.1,"value":50000.0,"ownership":{"direct":true},"balance_after":5022857,"source":{"system":"sec-edgar","filing":"0001437749-20-008575","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/922247/000143774920008575/rdgdoc.xml","form_type":"4"}},{"id":3429561,"issuer":{"id":82635,"kind":"organization","name":"Cyclo Therapeutics, Inc.","symbol":"CYTH"},"owners":[{"id":68386,"kind":"person","name":"Sieger Markus","position":1,"cik":"0001337143","reported_name":"Sieger Markus","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-08-26T16:04:25.000Z","date":"2019-08-23","kind":"purchase","acquired":true,"shares":100000,"price":0.22,"value":22000.0,"ownership":{"direct":true},"balance_after":4522857,"source":{"system":"sec-edgar","filing":"0001437749-19-017442","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/922247/000143774919017442/rdgdoc.xml","form_type":"4"}},{"id":3505475,"issuer":{"id":82635,"kind":"organization","name":"Cyclo Therapeutics, Inc.","symbol":"CYTH"},"owners":[{"id":68386,"kind":"person","name":"Sieger Markus","position":1,"cik":"0001337143","reported_name":"Sieger Markus","relationship":{"director":true}}],"security":"Warrant to Purchase Common Stock","published_at":"2019-06-03T14:35:35.000Z","date":"2019-05-31","kind":"purchase","acquired":true,"shares":400000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities consist of 400,000 \"Units\" purchased by the reporting person for $0.25 per Unit.  Each Unit consists of one share of Common Stock and a warrant to purchase one share of Common Stock."}],"balance_after":400000,"derivative":{"exercise_price":0.3,"exercise_date":"2019-05-31","expiration_date":"2024-11-30","underlying":"Common Stock","underlying_shares":400000},"source":{"system":"sec-edgar","filing":"0001437749-19-011249","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/922247/000143774919011249/rdgdoc.xml","form_type":"4"}},{"id":3505474,"issuer":{"id":82635,"kind":"organization","name":"Cyclo Therapeutics, Inc.","symbol":"CYTH"},"owners":[{"id":68386,"kind":"person","name":"Sieger Markus","position":1,"cik":"0001337143","reported_name":"Sieger Markus","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-06-03T14:35:35.000Z","date":"2019-05-31","kind":"purchase","acquired":true,"shares":400000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities consist of 400,000 \"Units\" purchased by the reporting person for $0.25 per Unit.  Each Unit consists of one share of Common Stock and a warrant to purchase one share of Common Stock."}],"balance_after":4422857,"source":{"system":"sec-edgar","filing":"0001437749-19-011249","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/922247/000143774919011249/rdgdoc.xml","form_type":"4"}},{"id":3718385,"issuer":{"id":82635,"kind":"organization","name":"Cyclo Therapeutics, Inc.","symbol":"CYTH"},"owners":[{"id":68386,"kind":"person","name":"Sieger Markus","position":1,"cik":"0001337143","reported_name":"Sieger Markus","relationship":{"director":true}}],"security":"Warrant to Purchase Common Stock","published_at":"2018-12-27T10:27:14.000Z","date":"2018-12-21","kind":"purchase","acquired":true,"shares":100000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities consist of 100,000 \"Units\" purchased by the reporting person for $0.65 per Unit.  Each Unit consists of one share of Common Stock and a warrant to purchase one share of Common Stock."}],"balance_after":100000,"derivative":{"exercise_price":0.65,"exercise_date":"2018-12-21","expiration_date":"2025-12-21","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001437749-18-022633","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/922247/000143774918022633/rdgdoc.xml","form_type":"4"}},{"id":3718384,"issuer":{"id":82635,"kind":"organization","name":"Cyclo Therapeutics, Inc.","symbol":"CYTH"},"owners":[{"id":68386,"kind":"person","name":"Sieger Markus","position":1,"cik":"0001337143","reported_name":"Sieger Markus","relationship":{"director":true}}],"security":"Common Stock","published_at":"2018-12-27T10:27:14.000Z","date":"2018-12-21","kind":"purchase","acquired":true,"shares":100000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities consist of 100,000 \"Units\" purchased by the reporting person for $0.65 per Unit.  Each Unit consists of one share of Common Stock and a warrant to purchase one share of Common Stock."}],"balance_after":4022857,"source":{"system":"sec-edgar","filing":"0001437749-18-022633","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/922247/000143774918022633/rdgdoc.xml","form_type":"4"}},{"id":3881668,"issuer":{"id":82635,"kind":"organization","name":"Cyclo Therapeutics, Inc.","symbol":"CYTH"},"owners":[{"id":68386,"kind":"person","name":"Sieger Markus","position":1,"cik":"0001337143","reported_name":"Sieger Markus","relationship":{"director":true}}],"security":"Series B Convertible Preferred Stock","published_at":"2018-06-28T16:02:35.000Z","date":"2018-05-23","kind":"exercise","acquired":false,"shares":500,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reflects the automatic conversion of Series B Convertible Preferred Stock (\"Series B Preferred\") into Common Stock upon the filing of Articles of Amendment to the Issuer's Articles of Incorporation increasing the Issuer's authorized shares of Common Stock.  The conversion is an exempt transaction pursuant to Rule 16b-7 under the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Series B Preferred were included in \"Units\" purchased by the reporting person for $100 per Unit.  Each Unit consisted of one share of Series B Preferred convertible into 400 shares of Common Stock and one warrant to purchase 400 shares of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Reflects the automatic conversion of Series B Convertible Preferred Stock (\"Series B Preferred\") into Common Stock upon the filing of Articles of Amendment to the Issuer's Articles of Incorporation increasing the Issuer's authorized shares of Common Stock.  The conversion is an exempt transaction pursuant to Rule 16b-7 under the Securities Exchange Act of 1934, as amended."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Reflects the automatic conversion of Series B Convertible Preferred Stock (\"Series B Preferred\") into Common Stock upon the filing of Articles of Amendment to the Issuer's Articles of Incorporation increasing the Issuer's authorized shares of Common Stock.  The conversion is an exempt transaction pursuant to Rule 16b-7 under the Securities Exchange Act of 1934, as amended."}],"balance_after":0,"derivative":{"exercise_price":0.25,"underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001437749-18-012611","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/922247/000143774918012611/rdgdoc.xml","form_type":"4"}},{"id":3881667,"issuer":{"id":82635,"kind":"organization","name":"Cyclo Therapeutics, Inc.","symbol":"CYTH"},"owners":[{"id":68386,"kind":"person","name":"Sieger Markus","position":1,"cik":"0001337143","reported_name":"Sieger Markus","relationship":{"director":true}}],"security":"Common Stock","published_at":"2018-06-28T16:02:35.000Z","date":"2018-05-23","kind":"exercise","acquired":true,"shares":200000,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reflects the automatic conversion of Series B Convertible Preferred Stock (\"Series B Preferred\") into Common Stock upon the filing of Articles of Amendment to the Issuer's Articles of Incorporation increasing the Issuer's authorized shares of Common Stock.  The conversion is an exempt transaction pursuant to Rule 16b-7 under the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Series B Preferred were included in \"Units\" purchased by the reporting person for $100 per Unit.  Each Unit consisted of one share of Series B Preferred convertible into 400 shares of Common Stock and one warrant to purchase 400 shares of Common Stock."}],"balance_after":3922857,"source":{"system":"sec-edgar","filing":"0001437749-18-012611","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/922247/000143774918012611/rdgdoc.xml","form_type":"4"}},{"id":3957442,"issuer":{"id":82635,"kind":"organization","name":"Cyclo Therapeutics, Inc.","symbol":"CYTH"},"owners":[{"id":68386,"kind":"person","name":"Sieger Markus","position":1,"cik":"0001337143","reported_name":"Sieger Markus","relationship":{"director":true}}],"security":"Warrant to Purchase Common Stock","published_at":"2018-04-25T16:02:33.000Z","date":"2018-04-23","kind":"purchase","acquired":true,"shares":100000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported securities consist of 250 \"Units\" purchased by the reporting person for $100 per Unit.  Each Unit consists of one share of Series B Preferred and warrants to purchase 400 shares of Common Stock."}],"balance_after":100000,"derivative":{"exercise_price":0.25,"exercise_date":"2018-04-23","expiration_date":"2025-04-23","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001437749-18-007689","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/922247/000143774918007689/rdgdoc.xml","form_type":"4"}},{"id":3957441,"issuer":{"id":82635,"kind":"organization","name":"Cyclo Therapeutics, Inc.","symbol":"CYTH"},"owners":[{"id":68386,"kind":"person","name":"Sieger Markus","position":1,"cik":"0001337143","reported_name":"Sieger Markus","relationship":{"director":true}}],"security":"Series B Convertible Preferred Stock","published_at":"2018-04-25T16:02:33.000Z","date":"2018-04-23","kind":"purchase","acquired":true,"shares":250,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported securities consist of 250 \"Units\" purchased by the reporting person for $100 per Unit.  Each Unit consists of one share of Series B Preferred and warrants to purchase 400 shares of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Series B Convertible Preferred Stock (\"Series B Preferred\") will automatically convert into Common Stock on the date the Issuer effects an increase of its authorized shares of Common Stock and/or a reverse stock split so that it has a sufficient number of authorized and unissued shares of Common Stock to permit the conversion or exercise, as applicable of all outstanding shares of Series B Preferred, warrants, options and other convertible securities of the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Series B Convertible Preferred Stock (\"Series B Preferred\") will automatically convert into Common Stock on the date the Issuer effects an increase of its authorized shares of Common Stock and/or a reverse stock split so that it has a sufficient number of authorized and unissued shares of Common Stock to permit the conversion or exercise, as applicable of all outstanding shares of Series B Preferred, warrants, options and other convertible securities of the Issuer."}],"balance_after":500,"derivative":{"exercise_price":0.25,"underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001437749-18-007689","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/922247/000143774918007689/rdgdoc.xml","form_type":"4"}},{"id":4077324,"issuer":{"id":82635,"kind":"organization","name":"Cyclo Therapeutics, Inc.","symbol":"CYTH"},"owners":[{"id":68386,"kind":"person","name":"Sieger Markus","position":1,"cik":"0001337143","reported_name":"Sieger Markus","relationship":{"director":true}}],"security":"Common Stock","published_at":"2018-02-05T16:28:29.000Z","date":"2018-02-01","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":3722857,"source":{"system":"sec-edgar","filing":"0001437749-18-001676","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/922247/000143774918001676/rdgdoc.xml","form_type":"4"}},{"id":4183226,"issuer":{"id":82635,"kind":"organization","name":"Cyclo Therapeutics, Inc.","symbol":"CYTH"},"owners":[{"id":68386,"kind":"person","name":"Sieger Markus","position":1,"cik":"0001337143","reported_name":"Sieger Markus","relationship":{"director":true}}],"security":"Warrant to Purchase Common Stock","published_at":"2017-10-19T16:01:40.000Z","date":"2017-10-18","kind":"purchase","acquired":true,"shares":100000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported securities consist of 250 \"Units\" purchased by the reporting person for $100 per Unit.  Each Unit consists of one share of Series B Preferred and warrants to purchase 400 shares of Common Stock."}],"balance_after":100000,"derivative":{"exercise_price":0.25,"exercise_date":"2017-10-18","expiration_date":"2024-10-18","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001437749-17-017325","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/922247/000143774917017325/rdgdoc.xml","form_type":"4"}},{"id":4183225,"issuer":{"id":82635,"kind":"organization","name":"Cyclo Therapeutics, Inc.","symbol":"CYTH"},"owners":[{"id":68386,"kind":"person","name":"Sieger Markus","position":1,"cik":"0001337143","reported_name":"Sieger Markus","relationship":{"director":true}}],"security":"Series B Convertible Preferred Stock","published_at":"2017-10-19T16:01:40.000Z","date":"2017-10-18","kind":"purchase","acquired":true,"shares":250,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported securities consist of 250 \"Units\" purchased by the reporting person for $100 per Unit.  Each Unit consists of one share of Series B Preferred and warrants to purchase 400 shares of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Series B Convertible Preferred Stock (\"Series B Preferred\") will automatically convert into Common Stock on the date the Issuer effects an increase of its authorized shares of Common Stock and/or a reverse stock split so that it has a sufficient number of authorized and unissued shares of Common Stock to permit the conversion or exercise, as applicable of all outstanding shares of Series B Preferred, warrants, options and other convertible securities of the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Series B Convertible Preferred Stock (\"Series B Preferred\") will automatically convert into Common Stock on the date the Issuer effects an increase of its authorized shares of Common Stock and/or a reverse stock split so that it has a sufficient number of authorized and unissued shares of Common Stock to permit the conversion or exercise, as applicable of all outstanding shares of Series B Preferred, warrants, options and other convertible securities of the Issuer."}],"balance_after":250,"derivative":{"exercise_price":0.25,"underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001437749-17-017325","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/922247/000143774917017325/rdgdoc.xml","form_type":"4"}},{"id":4362883,"issuer":{"id":82635,"kind":"organization","name":"Cyclo Therapeutics, Inc.","symbol":"CYTH"},"owners":[{"id":68386,"kind":"person","name":"Sieger Markus","position":1,"cik":"0001337143","reported_name":"Sieger Markus","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-04-04T16:08:00.000Z","date":"2017-03-31","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":3702857,"source":{"system":"sec-edgar","filing":"0001213900-17-003313","document":"f4033117sieger_ctdholdings.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/922247/000121390017003313/f4033117sieger_ctdholdings.xml","form_type":"4"}},{"id":4422657,"issuer":{"id":82635,"kind":"organization","name":"Cyclo Therapeutics, Inc.","symbol":"CYTH"},"owners":[{"id":68386,"kind":"person","name":"Sieger Markus","position":1,"cik":"0001337143","reported_name":"Sieger Markus","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant to Purchase Common Stock","published_at":"2017-02-27T12:20:09.000Z","date":"2017-02-23","kind":"purchase","acquired":true,"shares":142857,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities consist of 142,857 \"Units\" purchased by the reporting person for $0.35 per Unit. Each Unit consists of one share of common stock and one warrant to purchase one share of common stock."}],"balance_after":142857,"derivative":{"exercise_price":0.35,"exercise_date":"2017-02-23","expiration_date":"2024-02-23","underlying":"Common Stock","underlying_shares":142857},"source":{"system":"sec-edgar","filing":"0001213900-17-001797","document":"f4022317sieger_ctdholding.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/922247/000121390017001797/f4022317sieger_ctdholding.xml","form_type":"4"}},{"id":4422656,"issuer":{"id":82635,"kind":"organization","name":"Cyclo Therapeutics, Inc.","symbol":"CYTH"},"owners":[{"id":68386,"kind":"person","name":"Sieger Markus","position":1,"cik":"0001337143","reported_name":"Sieger Markus","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-02-27T12:20:09.000Z","date":"2017-02-23","kind":"purchase","acquired":true,"shares":142857,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities consist of 142,857 \"Units\" purchased by the reporting person for $0.35 per Unit. Each Unit consists of one share of common stock and one warrant to purchase one share of common stock."}],"balance_after":3682857,"source":{"system":"sec-edgar","filing":"0001213900-17-001797","document":"f4022317sieger_ctdholding.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/922247/000121390017001797/f4022317sieger_ctdholding.xml","form_type":"4"}}]}